Preclinical Research
Sanguinarine, an
alkaloid isolated from the root of Sanguinaria canadensis and other plants of the Papaveraceae family, selectively induces apoptotic cell death in a variety of human
cancer cells, but its mechanism of action requires further elaboration. The present study investigated the pro-apoptotic effects of
sanguinarine in human
oral squamous cell carcinoma KB cells.
Sanguinarine treatment increased DR5/TRAILR2 (
death receptor 5/
TRAIL receptor 2) expression and enhanced the activation of
caspase-8 and cleavage of its substrate, Bid.
Sanguinarine also induced the mitochondrial translocation of pro-apoptotic Bax,
mitochondrial dysfunction,
cytochrome c release to the cytosol, and activation of
caspase-9 and -3. However, a pan-
caspase inhibitor,
z-VAD-fmk, reversed the growth inhibition and apoptosis induced by
sanguinarine.
Sanguinarine also suppressed the phosphorylation of
phosphoinositide 3-kinase (PI3K) and Akt in KB cells, while co-treatment of cells with
sanguinarine and a PI3K inhibitor revealed synergistic apoptotic effects. However, pharmacological inhibition of
AMP-activated protein kinase and
mitogen-activated protein kinases did not reduce or enhance
sanguinarine-induced growth inhibition and apoptosis. Collectively, these findings indicate that the pro-apoptotic effects of
sanguinarine in KB cells may be regulated by a
caspase-dependent cascade via activation of both intrinsic and extrinsic signaling pathways and inactivation of PI3K/Akt signaling. Drug Dev Res 77 : 227-240, 2016. © 2016 Wiley Periodicals, Inc.